Concordia Healthcare to buy rare disease drugs maker for $1.9 billion: Reuters

Canada's Concordia Healthcare Corp (CXRX.O) (CXR.TO) said it would buy Amdipharm Mercury Ltd from private equity firm Cinven for $1.9 billion to expand its portfolio of drugs aimed at treating rare diseases, Reuters News reported.

DealsNorth AmericaUSBriefs